Uro-oncology

Partial table of contents:; Growth Factors and Genitourinary Cancer (S. Jacobs); SUPERFICIAL BLADDER CANCER; Immune Modifiers in the Treatment of Bladder Cancer (A. Morales); Immunocytology as a Possible Marker to Identify Patients Who Require Prophylaxis (H. Huland, et al.); Phase I/II Study of Intravesical Epirubicin in Patients with Carcinoma in Situ of the Bladder (K. Kurth, et al.); TREATMENT OF ADVANCED BLADDER CANCER; Overview of Systemic Treatment of Bladder Cancer and Results with M-VAC Therapy (A. Yagoda); Intraarterial Chemotherapy for Bladder Cancer (S. Jacobs & D. Menashe); PROSTATE CANCER; Overview of Hormonal Therapy for Prostate Cancer (H. Carter & J. Isaacs); Chemotherapy of Advanced Cancer of the Prostate (M. Wirth); SYSTEMIC TREATMENT OF RENAL CELL CANCER; Systemic Treatment for Renal Cell Carcinoma: An Overview (D. Swanson); Cyclic Interferon Gamma Application in Patients with Renal Cell Carcinoma (J. Grups & H. Frohm; ller); TREATMENT OF GERM CELL TUMORS; Overview: Treatment of Local Regional Disease (J. Donohue); Intensive Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumors (C. Logothetis, et al.); Index.